netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 20: Miscellaneous products - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

 Details...
20  Miscellaneous preparations
 note 
Acetylcysteine injection (poisoning)
View adult BNF View SPC online
Formulary
Red
For use in paracetamol overdose. Follow local protocols and advice from the National Poisons Information Centre 
   
Tisseel® fibrin sealant
Formulary
Red

Must be used in accordance with a local Trust-approved guideline

For supportive treatment in surgery for improvement of haemostasis where standard techniques are insufficient

 
   
Tisseel® fibrin sealant (off-label uses)
Formulary
Red

Approved off-label indication:

For sealing the conjunctival graft during pterygium surgery

 
   
Evicel® fibrin sealant
Formulary
Red

Must be used in accordance with a local Trust-approved guideline

For supportive treatment in surgery for improvement of haemostasis where standard techniques are insufficient

 
   
Floseal® haemostatic matrix
Formulary
Red
Neurosurgery 
   
Surgiflo® haemostatic matrix kit
Formulary
Red
Neurosurgery 
Link  SE London APC Recommendation: SURGIFLO haemostatic matrix for bleeding in neurological procedures
   
Tachosil® medicated sponge (haemostasis in surgery)
Formulary
Red

To be used in accordance with a local Trust-approved guideline

  • For supportive treatment in surgery for improvement of haemostasis where standard techniques are insufficient
 
   
Tachosil® medicated sponge (sealing of the dura mater in neurosurgery)
Formulary
Red

To be used in accordance with a local Trust-approved guideline

  • For supportive treatment in neurosurgery, including supportive sealing of the dura mater to prevent postoperative cerebrospinal fluid leakage.
 
   
TauroLock® catheter lock solution
Formulary
Red
For patients receiving long term, home parenteral nutrition who have experienced one episode of confirmed catheter-related blood stream infection (CRBSI) 
   
TauroLock® HEP500 catheter lock solution
Formulary
Red
Restricted as second-line alternative to trisodium citrate 46.7% for patients
  • Who are IVDUs or
  • Can not tolerate high levels of citrate, or
  • In dialysis patients with recurrent bacteraemia 
  •    
    Trisodium citrate 46.7% catheter lock solution
    Formulary
    Red
    Antimicrobial and anticoagulant catheter locking solution for central venous catheters used in renal dialysis patients 
       
     ....
     Non Formulary Items
    Herbal treatments

    Non Formulary
    Grey

    Not for prescribing in SE London

    Link  SE London APC: Patient Information Leaflet: Changes to herbal treatment prescribing
     
    Homeopathy treatments

    Non Formulary
    Grey

    Not for prescribing in SE London

    Link  SE London APC: Patient Information Leaflet: Changes to homeopathic remedy prescribing
     
      
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to SPCs
    SMC
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Red

    Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

    Amber 1

    Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

    Amber 2

    Specialist initiation followed by maintenance prescribing in primary care  

    Amber 3

    Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

    Green

    Specialist and non-specialist initiation  

    Grey

    Not recommended for prescribing  

    netFormulary